Molecular and cellular glycobiology

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Oxford Oxford Univ. Press 2000
Ausgabe:1. publ.
Schriftenreihe:Frontiers in molecular biology
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 c 4500
001 BV013283319
003 DE-604
005 20070116
007 t
008 000802s2000 d||| |||| 00||| eng d
020 |a 0199638071  |9 0-19-963807-1 
020 |a 0199638063  |9 0-19-963806-3 
035 |a (OCoLC)43978037 
035 |a (DE-599)BVBBV013283319 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-355  |a DE-M49 
050 0 |a QP702.G577 
082 0 |a 612/.01578  |2 21 
084 |a WD 5650  |0 (DE-625)148212:  |2 rvk 
084 |a BIO 200f  |2 stub 
084 |a CHE 887f  |2 stub 
245 1 0 |a Molecular and cellular glycobiology  |c ed. by Minoru Fukuda ... 
250 |a 1. publ. 
264 1 |a Oxford  |b Oxford Univ. Press  |c 2000 
300 |a XXI, 289 S.  |b graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 0 |a Frontiers in molecular biology 
650 4 |a Carbohydrates  |x Metabolism  |x Disorders 
650 4 |a Carbohydrates  |x Physiological effect 
650 4 |a Carbohydrates  |x physiology 
650 4 |a Glycoconjugates 
650 4 |a Glycoconjugates  |x Physiological effect 
650 4 |a Glycolipids  |x physiology 
650 4 |a Glycoproteins  |x physiology 
650 0 7 |a Glykokonjugate  |0 (DE-588)4131221-1  |2 gnd  |9 rswk-swf 
650 0 7 |a Biomembran  |0 (DE-588)4006884-5  |2 gnd  |9 rswk-swf 
689 0 0 |a Biomembran  |0 (DE-588)4006884-5  |D s 
689 0 1 |a Glykokonjugate  |0 (DE-588)4131221-1  |D s 
689 0 |5 DE-604 
700 1 |a Fukuda, Minoru  |d 1945-  |e Sonstige  |0 (DE-588)132497719  |4 oth 
856 4 2 |m HBZ Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009055573&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
999 |a oai:aleph.bib-bvb.de:BVB01-009055573 

Datensatz im Suchindex

DE-BY-TUM_call_number 1002/CHE 887f 10.2001 A 440
DE-BY-TUM_katkey 1233474
DE-BY-TUM_media_number 040004140390
_version_ 1816712115666288640
adam_text Contents List of contributors xvii Abbreviations xix 1. Cell surface carbohydrates: cell type specific expression 1 MINORU FUKUDA 1. Introduction 1 2. Structure of IV glycans 4 2.1 Diversity of N glycans 5 2.2 Shared features of N glycans 8 2.3 Defects in N glycan biosynthesis 11 3. Cell type specific expression of N glycans 12 3.1 Poly N acetyllactosamines—glycans with N acetyllactosamine repeats 12 3.2 Cell type specific modification of poly N acetyllactosamines 17 3.3 Polysialic acid and HNK 1 glycans 20 4. O glycans 23 4.1 Mucin type O glycans—distribution and role 24 4.2 Mucin type glycoproteins in the plasma membrane: glycophorin A and leukosialin 25 4.3 Structures of mucin type oligosaccharides: cell type specific expression 26 4.4 Changes in mucin type oligosaccharides in tumors and immunodeficiency 28 4.5 Properties of core 2 and I branching pi,6 N acetylglucosaminyl transferases 31 5. Roles of cell surface carbohydrates 33 5.1 Roles of cell surface carbohydrates in leukocytes 33 5.2 Roles of mucin type O glycans in cell adhesion 38 5.3 Poly N acetyllactosaminylation in tumor cells 41 6. Glycobiology—new frontiers in cell and molecular biology 44 Acknowledgements 47 References 47 2 Carbohydrate recognition in leukocyte endothelial cell interactions 62 JONATHON W. HOMEISTER AND JOHN B. LOWE 1. Introduction 62 2. Oligosaccharides in lymphocyte homing 63 2.1 General aspects of lymphocyte homing 63 2.2 Lymphocyte PNHEV adhesive interactions are oligosaccharide dependent 64 2.3 The MEL 14 homing receptor contains a carbohydrate recognition domain 66 2.4 Functions of the domains of L selectin 68 2.5 GlyCAM 1 as an L selectin counter receptor 69 2.6 CD34 as an L selectin counter receptor 70 2.7 MAdCAM 1 as an L selectin counter receptor 71 2.8 Podocalyxin like protein (PCLP) as an L selectin counter receptor 71 2.9 Glycoconjugate structures that contribute to the adhesive activity of HEV borne L selectin counter receptors 71 2.10 L selectin is required for normal lymphocyte homing; the L selectin null mouse 74 2.11 L selectin expression and its function in neutrophil and monocyte adhesion to vascular endothelium 74 2.12 Mechanisms for L selectin dependent neutrophil and monocyte adhesion and recruitment 76 3. Oligosaccharide dependent cell adhesion mediated by E selectin 77 3.1 E selectin dependent adhesion of myeloid cells to activated endothelium 77 3.2 Regulation of E selectin expression 77 3.3 E selectin contains a CRD similar to the L selectin CRD 78 3.4 Ligands for E selectin 81 4. Oligosaccharide dependent cell adhesion mediated by P selectin 88 4.1 Regulation of P selectin expression 88 4.2 P selectin includes a CRD and is structurally similar to L and E selectins 89 4.3 P selectin dependent adhesion of myeloid cells to endothelium and activated platelets 90 4.4 Glycan contributions to P selectin counter receptor activity 92 4.5 Ligands for P selectin—evidence for a protein component in addition to sialylated, fucosylated oligosaccharides 93 4.6 P selectin glycoprotein ligand 1 (PSGL 1) and its post translational modifications 94 4.7 Ligands for P selectin—evidence that P selectin dependent cell adhesion may also operate through sulfatides 96 5. The sequential, multi molecule model for leukocyte rolling, adhesion and transmigration 97 Acknowledgements 99 References 99 3. Polysialic acid in neural cell development: roles, regulation and mechanism 116 JUAN L. BRUSES AND URS RUTISHAUSER 1. Introduction 116 2. Biological roles of PS A 117 2.1 Cell migration 117 2.2 Axonal guidance 119 2.3 Synapse formation 120 2.4 Plasticity in the nervous system 121 3. Regulation of PSA expression 122 3.1 Biosynthesis of PSA on NCAM 123 3.2 Delivery of PSA NCAM to the cell membrane 125 3.3 Removal of PSA NCAM from the cell surface 125 4. Mechanisms of PSA action 125 4.1 Steric models 126 4.2 Local pH 127 4.3 Binding to PSA 127 5. Epilogue: the phylogeny of PSA NCAM 127 References 128 4. Diseases with deficiencies in asparagine linked glycosylation 133 A. Carbohydrate deficient glycoprotein syndromes 133 HARRY SCHACHTER 1. Introduction 133 2. Carbohydrate deficient glycoprotein syndrome type I 133 2.1 Clinical and pathological features of CDG I 135 2.2 Clinical biochemistry of CDG I 135 2.3 CDG la 138 2.4 CDG I with normal PMM activity 141 3. Complex N glycan synthesis within the Golgi apparatus 144 4. Carbohydrate deficient glycoprotein syndrome type II (CDG II) 145 4.1 Clinical features and clinical biochemistry of CDG II 145 4.2 The biochemical defect in CDG II 146 Acknowledgement 147 References 147 B. Congenital dyserythropoietic anemia type II (HEMPAS) 158 MICHIKO N. FUKUDA 1. Introduction 158 2. Incidence and symptoms of HEMPAS 158 3. Biochemical characteristics of HEMPAS 160 4. Genetic analysis of HEMPAS 162 5. An animal model of HEMPAS 163 6. Why does a glycosylation defect result in anemia? 163 7. Unsolved problems 164 Acknowledgements 165 References 165 5. Functions of carbohydrates revealed by transgenic technology 169 PAMELA STANLEY 1. Introduction 169 2. The first mouse glycosylation mutants 169 3. Insights from transgenic mice that misexpress or overexpress a glycosyltransf erase 171 3.1 Misexpression as a probe for function 171 3.2 Misexpression as a probe for substrates 173 3.3 Misexpression as a competitive force 174 4. Insights from mice with targeted gene mutations 175 4.1 Targeted mutations that cause embryonic lethality 175 4.2 Targeted mutations that identify compensatory molecules 178 4.3 Targeted mutations that have resolved specific hypotheses 178 4.4 Conditional targeted mutations 179 4.5 Identifying cell type specific defects in chimeras 180 4.6 Targeted mutations that reveal unsuspected phenotypes 181 5. Considerations for the next generation of mouse glycosylation mutants 183 5.1 Transgenic mice 183 5.2 Mice with a targeted mutation 184 6. Challenges for the new millenium 187 Acknowledgements 189 References 189 6. Functional significance of O GlcNAc glycoproteins in the nucleus and cytoplasm 199 LISA K. KREPPEL AND GERALD W. HART 1. Introduction 199 2. Dynamic O GlcNAcylation of proteins 199 2.1 Sites of O GlcNAc attachment 200 2.2 O GlcNAc is a dynamic modification 201 3. Nuclear O GlcNAcylation 204 3.1 Transcription 204 3.2 Oncogenes and tumor suppressor proteins 205 3.3 Nuclear pore complex and nuclear transport 207 4. Cytoplasmic O GlcNAcylation 208 4.1 Cytoskeletal proteins 209 4.2 Protein synthesis 211 4.3 GTP binding protein function 212 5. Conclusion 213 References 214 7. Roles of sphingolipids and glycosphingolipids in biological membranes 220 YOSHIO HIRABAYASHI AND SHINICHI ICHIKAWA 1. Introduction 220 2. General features of membrane sphingolipids 221 2.1 Chemical structure and distribution of sphingolipids 221 2.2 Localization of sphingolipids: sphingolipid domains as an information base in biological membranes 222 2.3 Diverse functions of ceramide and its metabolites 225 3. Metabolism of complex sphingolipids 225 3.1 Biosynthesis of ceramide in endoplasmic reticulum membrane 225 3.2 Biosynthesis of GSLs in the Golgi membrane 227 3.3 Molecular cloning of other GSL glycosyltransferases 234 4. Roles of sphingolipids revealed by studies of mutant cells 234 4.1 SPB 1: CHO cells deficient in an entire group of sphingolipids 235 4.2 GM 95, a melanoma cell deficient in all GSLs 235 4.3 FUA169/F28 7 mouse mammary carcinoma cells with different degrees of GM3 expression 236 4.4 Embryonic stem cells deficient in b series gangliosides 236 5. Studies of sphingolipid function at the whole animal level 237 5.1 GM2 synthase: GM3 and GD3 can compensate for depletion of complex gangliosides 237 5.2 Galactosylceramide synthase: galactosylceramide is not involved in cell differentiation but is an essential component of myelin 238 6. Conclusion 238 References 239 8. Carbohydrates in medicine 249 JOSEPH C. McAULIFFE AND OLE HINDSGAUL 1. Introduction 249 2. Why carbohydrates? 249 2.1 Carbohydrate based drugs 250 2.2 Carbohydrate modified drugs 253 2.3 Carbohydrates as drug delivery agents 254 3. Targets of carbohydrate therapeutics 255 3.1 Gastrointestinal receptors 255 3.2 Serum receptors 255 3.3 Cell surface receptors 256 3.4 Bacterial and viral receptors 256 3.5 Intracellular receptors 257 3.6 Extracellular matrix 257 4. Examples of carbohydrate based drugs 258 4.1 Antibiotics 258 4.2 Anti infective agents 259 4.3 Cancer 261 4.4 Diabetes 263 4.5 Inflammatory diseases 264 4.6 Inborn errors of metabolism 267 4.7 Polysaccharide vaccines 267 4.8 Anticoagulant and thrombolytic therapeutics 268 4.9 Immunomodulatory agents 268 4.10 Neurological diseases 269 5. Examples of carbohydrate modified drugs 271 5.1 Antibiotics 271 5.2 Cancer therapeutics 271 5.3 Analgesics 273 6. Examples of carbohydrates in drug delivery 273 6.1 Polysaccharides 273 6.2 Miscellaneous agents used in drug delivery 274 7. Conclusion 275 Acknowledgements 275 References 275 Index 281
any_adam_object 1
author_GND (DE-588)132497719
building Verbundindex
bvnumber BV013283319
callnumber-first Q - Science
callnumber-label QP702
callnumber-raw QP702.G577
callnumber-search QP702.G577
callnumber-sort QP 3702 G577
callnumber-subject QP - Physiology
classification_rvk WD 5650
classification_tum BIO 200f
CHE 887f
ctrlnum (OCoLC)43978037
(DE-599)BVBBV013283319
dewey-full 612/.01578
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 612 - Human physiology
dewey-raw 612/.01578
dewey-search 612/.01578
dewey-sort 3612 41578
dewey-tens 610 - Medicine and health
discipline Biologie
Chemie
Medizin
edition 1. publ.
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01841nam a2200505 c 4500</leader><controlfield tag="001">BV013283319</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070116 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000802s2000 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199638071</subfield><subfield code="9">0-19-963807-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199638063</subfield><subfield code="9">0-19-963806-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)43978037</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013283319</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-M49</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP702.G577</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">612/.01578</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WD 5650</subfield><subfield code="0">(DE-625)148212:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIO 200f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 887f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular and cellular glycobiology</subfield><subfield code="c">ed. by Minoru Fukuda ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 289 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Frontiers in molecular biology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carbohydrates</subfield><subfield code="x">Metabolism</subfield><subfield code="x">Disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carbohydrates</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carbohydrates</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glycoconjugates</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glycoconjugates</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glycolipids</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Glycoproteins</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Glykokonjugate</subfield><subfield code="0">(DE-588)4131221-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biomembran</subfield><subfield code="0">(DE-588)4006884-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Biomembran</subfield><subfield code="0">(DE-588)4006884-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Glykokonjugate</subfield><subfield code="0">(DE-588)4131221-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fukuda, Minoru</subfield><subfield code="d">1945-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)132497719</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=009055573&amp;sequence=000002&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009055573</subfield></datafield></record></collection>
id DE-604.BV013283319
illustrated Illustrated
indexdate 2024-11-25T17:19:56Z
institution BVB
isbn 0199638071
0199638063
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-009055573
oclc_num 43978037
open_access_boolean
owner DE-355
DE-BY-UBR
DE-M49
DE-BY-TUM
owner_facet DE-355
DE-BY-UBR
DE-M49
DE-BY-TUM
physical XXI, 289 S. graph. Darst.
publishDate 2000
publishDateSearch 2000
publishDateSort 2000
publisher Oxford Univ. Press
record_format marc
series2 Frontiers in molecular biology
spellingShingle Molecular and cellular glycobiology
Carbohydrates Metabolism Disorders
Carbohydrates Physiological effect
Carbohydrates physiology
Glycoconjugates
Glycoconjugates Physiological effect
Glycolipids physiology
Glycoproteins physiology
Glykokonjugate (DE-588)4131221-1 gnd
Biomembran (DE-588)4006884-5 gnd
subject_GND (DE-588)4131221-1
(DE-588)4006884-5
title Molecular and cellular glycobiology
title_auth Molecular and cellular glycobiology
title_exact_search Molecular and cellular glycobiology
title_full Molecular and cellular glycobiology ed. by Minoru Fukuda ...
title_fullStr Molecular and cellular glycobiology ed. by Minoru Fukuda ...
title_full_unstemmed Molecular and cellular glycobiology ed. by Minoru Fukuda ...
title_short Molecular and cellular glycobiology
title_sort molecular and cellular glycobiology
topic Carbohydrates Metabolism Disorders
Carbohydrates Physiological effect
Carbohydrates physiology
Glycoconjugates
Glycoconjugates Physiological effect
Glycolipids physiology
Glycoproteins physiology
Glykokonjugate (DE-588)4131221-1 gnd
Biomembran (DE-588)4006884-5 gnd
topic_facet Carbohydrates Metabolism Disorders
Carbohydrates Physiological effect
Carbohydrates physiology
Glycoconjugates
Glycoconjugates Physiological effect
Glycolipids physiology
Glycoproteins physiology
Glykokonjugate
Biomembran
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009055573&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv AT fukudaminoru molecularandcellularglycobiology